Category
Atenolol
CAS Number
61698-76-8
Molecular Formula
C₁₁H₁₅NO₄
Molecular Weight
225.24 g/mol
Synonym

4-(2,3-Dihydroxypropoxy)benzeneacetamide; 2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide; Benzeneacetamide, 4-(2,3-dihydroxypropoxy); 2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide; (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide); Atenolol Related Compound B (USP);

Keywords
Fine Chemicals
Aromatics
Amines
Pharmaceutical Standards
Impurities Manufacturer in India
Impurities
Intermediates
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

As a leading manufacturer and supplier of Atenol EP Impurity B, Manasa Life Sciences supports pharmaceutical research, analytical testing, and synthesis research and development through experienced scientists and comprehensive technical capabilities. Our services include custom synthesis, route scouting, process optimization, impurity profiling, structural characterization, scale-up studies, and analytical method development for Atenol EP Impurity B and related pharmaceutical impurities.

Manasa Life Sciences provides comprehensive analytical documentation, including HPLC, LC-MS/MS, NMR (¹³C and ¹H NMR), FTIR, GC, QNMR, and TGA, along with Potency/COA. We also provide SER (Structural Elucidation Report), MSDS, regulatory submission documents, and other documentation as per customer requirements. Our analytical and documentation services are designed to support pharmaceutical quality control, impurity identification, characterization, method development, regulatory submissions, and R&D requirements, with consideration of applicable ICH, EMA, USP, and EP (European Pharmacopoeia) guidelines and standards.